Преглед тема: "3D-QSAR"
Приказ резултата 1-20 од 21
-
3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists / 3D-QSAR modelovanje i analiza farmakofore antagonista serotoninskih 5-HT2A receptora
(Savez farmaceutskih udruženja Srbije, Beograd, 2017) -
3D-QSAR studija i razvoj farmakofore za dizajn novih antidepresiva sa dejstvom na transportere serotonina i histaminske H3 receptore / 3D-QSAR study and pharmacophore development of novel antidepressants affecting serotonine transporters and histamine H3 receptors
(Univerzitet Crne Gore Farmaceutski fakultet, Farmaceutska komora Crne Gore, 2015) -
3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists / 3D-QSAR studija i razvoj farmakofore agonista serotoninskih 5-HT2A receptora
(Savez farmaceutskih udruženja Srbije, Beograd, 2017) -
3D-Quantitative Structure-Activity Relationship and design of novel Rho- associated protein kinases-1 (ROCK1) inhibitors
(Institute for Information Technologies, University of Kragujevac, Serbia, 2023) -
Application of computational methods for antipsychotic drug design and optimization
(10th International Conference on Biotechnology and Bioengineering (ICBB2020). Dec. 16-18, 2020. Virtual conference, 2020) -
Combined 3D-QSAR modeling, molecular dynamics and molecular docking studies in rational drug design of novel 5-HT2A antagonists
(University of Kragujevac, Kragujevac, Serbia, Bioengineering Reserach and Development Centre BioIRC, 2019) -
Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase-6 Inhibitors
(Wiley-VCH Verlag GMBH, Weinheim, 2019) -
Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods
(Bentham Science Publishers, 2022) -
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease
(Elsevier France-Editions Scientifiques Medicales Elsevier, Issy-Les-Moulineaux, 2014) -
Highly selective anthraquinone-chalcone hybrids as potential antileukemia agents
(Pergamon-Elsevier Science Ltd, Oxford, 2018) -
Molecular modeling of 5 [(amidobenzyl)oxy] nicotinamides as sirtuin 2 inhibitors using alignment - (in)dependent 3D-QSAR analysis and molecular docking
(Institute for Information Technologies, University of Kragujevac, Serbia, 2021) -
Određivanje strukture farmakofore, dizajn i in vitro ispitivanje liganada sa višestrukim dejstvom kao potencijalno efikasnijih terapeutika složenih neuroloških i mentalnih oboljenja / Pharmacophore analysis, design and in vitro testing of multi-target ligands as potentially effective therapeutics of complex neurological and mental disorders
(Универзитет у Београду, Фармацеутски факултет, 2022) -
Pharmacophore modeling, drug design and virtual screening on multi-targeting procognitive agents approaching histaminergic pathways
(Elsevier Science BV, Amsterdam, 2015) -
Racionalni dizajn, sinteza i in vitro ispitivanja selektivnih inhibitora histon deacetilaze 6 / Rational design, synthesis and in vitro evaluation of selective histone deacetylase 6 inhibitors
(Универзитет у Београду, Фармацеутски факултет, 2022)